Steward Partners Investment Advisory’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,000
| Closed | -$26.2K | – | 3978 |
|
2024
Q3 | $26.2K | Sell |
2,000
-300
| -13% | -$3.94K | ﹤0.01% | 2540 |
|
2024
Q2 | $32.3K | Hold |
2,300
| – | – | ﹤0.01% | 2307 |
|
2024
Q1 | $38.8K | Hold |
2,300
| – | – | ﹤0.01% | 2229 |
|
2023
Q4 | $32.5K | Hold |
2,300
| – | – | ﹤0.01% | 2155 |
|
2023
Q3 | $23.7K | Hold |
2,300
| – | – | ﹤0.01% | 2227 |
|
2023
Q2 | $37.9K | Hold |
2,300
| – | – | ﹤0.01% | 1999 |
|
2023
Q1 | $21.1K | Hold |
2,300
| – | – | ﹤0.01% | 2230 |
|
2022
Q4 | $16.5K | Hold |
2,300
| – | – | ﹤0.01% | 2335 |
|
2022
Q3 | $12K | Hold |
2,300
| – | – | ﹤0.01% | 2436 |
|
2022
Q2 | $6K | Buy |
2,300
+1,500
| +188% | +$3.91K | ﹤0.01% | 2672 |
|
2022
Q1 | $5K | Buy |
800
+500
| +167% | +$3.13K | ﹤0.01% | 2865 |
|
2021
Q4 | $2K | Hold |
300
| – | – | ﹤0.01% | 2999 |
|
2021
Q3 | $3K | Hold |
300
| – | – | ﹤0.01% | 2907 |
|
2021
Q2 | $2K | Sell |
300
-14,302
| -98% | -$95.3K | ﹤0.01% | 6849 |
|
2021
Q1 | $132K | Buy |
14,602
+8,052
| +123% | +$72.8K | ﹤0.01% | 1483 |
|
2020
Q4 | $44K | Sell |
6,550
-2,000
| -23% | -$13.4K | ﹤0.01% | 1719 |
|
2020
Q3 | $43K | Buy |
8,550
+1,980
| +30% | +$9.96K | ﹤0.01% | 1561 |
|
2020
Q2 | $53K | Buy |
6,570
+520
| +9% | +$4.2K | ﹤0.01% | 1386 |
|
2020
Q1 | $48K | Buy |
6,050
+1,750
| +41% | +$13.9K | ﹤0.01% | 1275 |
|
2019
Q4 | $32K | Buy |
4,300
+4,000
| +1,333% | +$29.8K | ﹤0.01% | 1576 |
|
2019
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 2494 |
|
2019
Q2 | $0 | Buy |
+300
| New | – | ﹤0.01% | 2607 |
|
2018
Q4 | – | Sell |
-300
| Closed | -$1K | – | 867 |
|
2018
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 2466 |
|
2018
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 2194 |
|
2018
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 1987 |
|
2017
Q4 | $2K | Buy |
+300
| New | +$2K | ﹤0.01% | 1683 |
|